| Income Statement | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Research and development | 22,474 | 21,170 | ||
| In-process research and development | 2,000 | 7,500 | ||
| General and administrative | 10,072 | 9,455 | ||
| Total operating expenses | 34,546 | 38,125 | ||
| Loss from operations | -34,546 | -38,125 | ||
| Other expense, net | - | 81 | ||
| Interest income | 3,971 | 4,330 | ||
| Other (expense) income, net | -37 | - | ||
| Total other income (expense), net | 3,934 | 4,249 | ||
| Net loss | -30,612 | -33,876 | ||
| Unrealized gain on marketable securities, net | 234 | -213 | ||
| Comprehensive loss | -30,378 | -34,089 | ||
| Net loss per share, basic | -0.11 | -0.12 | ||
| Net loss per share, diluted | -0.11 | -0.12 | ||
| Weighted-average shares of common stock used in computing net loss per share, basic | 283,681,570 | 283,355,730 | ||
| Weighted-average shares of common stock used in computing net loss per share, diluted | 283,681,570 | 283,355,730 | ||
Erasca, Inc. (ERAS)
Erasca, Inc. (ERAS)